佳学基因对Factor V Leiden易栓症的发生进行了基因解码,并将之收入《人的基因序列变化与人体疾病表征》中,便于医生选择和使用,进行Factor V Leiden易栓症遗传阻断,也便于患者更好地进行治疗和健康管理。 Factor V Leiden易栓症疾病介绍: Factor V Leiden易栓症是一种遗传性血液凝固障碍。Factor V Leiden是导致易...
Factor V Leiden MutationVenous ThromboembolismPubMed comprises more than 22 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.doi:10.3109/09513599609045635...
Synonyms for Factor V Leiden mutation in Free Thesaurus. Antonyms for Factor V Leiden mutation. 34 synonyms for mutation: anomaly, variation, deviant, freak of nature, change, variation, evolution, transformation, modification, alteration, deviation...
mutation noun 1.The process or result of making or becoming different: alteration,change,modification,permutation,variation. 2.The process or result of changing from one appearance, state, or phase to another: change,changeover,conversion,metamorphosis,shift,transfiguration,transformation,translation,transmog...
factor V Lei·den -ˈlī-dᵊn 1 : a point mutation producing an abnormal version of factor V that is resistant to inactivation and causes prolonged clotting of blood 2 also factor V Leiden thrombophilia : a genetic disorder caused by factor V Leiden that is marked by an ...
5-10 µg/mL - 产品规格 种属反应 Human 宿主/亚型 Mouse / IgG1 分类 Monoclonal 类型 Antibody 克隆号 5110 抗原 120kD activation peptide of human factor V. 偶联物 Unconjugated 形式 Liquid 纯化类型 SDS-PAGE 保存液 50% water with 50% glycerol 内含物 no pre...
5-10 µg/mL - 产品规格 种属反应 Human 宿主/亚型 Mouse / IgG 分类 Monoclonal 类型 Antibody 克隆号 5146 抗原 Human factor V and heavy chain of factor Va. 偶联物 Unconjugated 形式 Liquid 浓度 9.2 mg/mL 纯化类型 SDS-PAGE 保存液 50% water with 50% glyc...
factor V Lei·den -ˈlī-dᵊn 1 : a point mutation producing an abnormal version of factor V that is resistant to inactivation and causes prolonged clotting of blood 2 also factor V Leiden thrombophilia : a genetic disorder caused by factor V Leiden that is marked by an ...
The incidence of deep vein thrombosis (DVT) in individuals with heterozygous Factor V Leiden mutation is low. However, DVT risk may be substantially increased when accompanied by nephrotic syndrome. Anticoagulation remains the mainstay of therapy but intervention may be necessary in clinically severe ...
Heterozygosity for Factor V Leiden occurs in 3– 8% of the general US and Euro- pean populations. The highest heterozygosity rate is found in Europe; the mutation is extremely rare in Asian, African, and indigenous Australian populations. Within Europe, the preva- lence varies from 10 to 15...